Search Results 201-210 of 15283 for CLL
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...
-
Idelalisib is used in combination with rituximab to treat chronic lymphocytic leukemia (CLL) that has come back after other treatment. Idelalisib interferes ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.
-
Mayo Clinic doctors and researchers are studying chronic lymphocytic leukemia to look for new ways to improve diagnosis and treatment for this cancer. Cancer ...
-
Acalabrutinib is FDA approved for treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma. Durvalumab is FDA approved for treatment in lung ...
-
This episode of "Tomorrow's Cure" explores how a type of blood cancer, chronic lymphocytic leukemia (CLL), is hard to detect early in its development and ...
-
... chronic lymphocytic leukemia (CLL). Most newly-diagnosed CLL patients have early-stage disease at the time of diagnosis and do not require treatment.